Prognostic Value of Mutations in TP53 and RAS Genes in Breast Cancer
The identification of molecular indicators of higher risk for specific subgroups of cancer patients may allow to develop more aggressive therapeutic strategies aimed at cases with the highest likelihood of response. This would avoid unnecessary toxicity to patients and alleviate the burden of cancer...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publishing
2003-01-01
|
| Col·lecció: | The International Journal of Biological Markers |
| Accés en línia: | https://doi.org/10.1177/172460080301800108 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|